DR.REDDY'S LABORATORIES LTD. - Form 6-K for the quarter ended December 31, 2016, filed with United States Securities Exchange Commission

Dr Reddys Laboratories Ltd has informed BSE that the Company has filed its unaudited condensed consolidated interim financial statements prepared under IFRS in Form 6-K for the quarter ended December 31, 2016, with the United States Securities Exchange Commission on February 10, 2017. A copy of the Form 6-K is attached.